Carlton arrives at the country club after working out and chats up Nicole. He quickly kisses her on the cheek before taking a ...
Researchers reveal structure of ancient viral protein appearing in breast cancer, lupus, and ALS, opening new paths for ...
When the alarm clock sounds before the sun comes up on a Saturday or Sunday morning in late January, Dan and Jennifer O'Hara have a fleeting moment when they consider hitting the off button instead of ...
Scott Soefje, PharmD, outlines proactive financial screening, flexible payment models, and stronger academic-community ...
Immunotherapy has emerged in recent years as a new cancer treatment that is gentler than traditional chemotherapy and causes ...
A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors and sometimes eliminating them entirely.
Rafta, a senior Shih Tzu abandoned in neglect, was saved by rescue after suffering a painful mass. He's now healing, ...
In July, the FDA issued a complete response letter (CRL) for Replimune's biologics license application for RP1 (vusolimogene ...
Determined to get answers, Glass flew to Bethesda, Maryland, just eight days after the call. At the NIH, she underwent a full-body MRI, met with an oncologist, and had comprehensive blood work done.
University of Iowa doctoral student Katie Colling is making progress in identifying hormones that are effective at combating uterine cancer.
Pancreatic cancer is one of the deadliest cancers, largely because it is usually discovered only after it has spread to other ...
Wall Street analysts have painted a tantalizing picture of triple-digit upside potential for some of this year’s worst-performing biotech names. Yet investors may want to temper their excitement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback